AI Verdict
MD has stronger fundamentals based on our AI analysis.
MD vs MCS Fundamental Comparison
| Metric | MD | MCS |
|---|---|---|
| Revenue | $1.9B | $758.5M |
| Net Income | $165.4M | $12.7M |
| Net Margin | 8.6% | 1.7% |
| ROE | 19.1% | 2.8% |
| ROA | 7.4% | 1.3% |
| Current Ratio | 1.66x | 0.40x |
| Debt/Equity | 0.69x | 0.35x |
| EPS | $1.94 | $0.77 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MD vs MCS: Frequently Asked Questions
Is MD or MCS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MD has stronger fundamentals. MD is rated HOLD (62% confidence) while MCS is rated SELL (75% confidence). This is not investment advice.
How does MD compare to MCS fundamentally?
Pediatrix Medical Group, Inc. has ROE of 19.1% vs MARCUS CORP's 2.8%. Net margins are 8.6% vs 1.7% respectively.
Which stock pays higher dividends, MD or MCS?
MD has a dividend yield of N/A or no dividend while MCS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MD or MCS for long term?
For long-term investing, consider that MD has HOLD rating with 62% confidence, while MCS has SELL rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MD vs MCS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MD vs MCS, the AI consensus favors MD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.